PP PAION
Live / Allowed — Published for opposition (as of 24 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 02 Apr 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 79424345
- Mark type
- Design + words
- Filed
- 02 Apr 2025
- Published for opposition
- 24 Mar 2026
- Attorney of record
- Leigh Ann Lindquist
Goods and services
- Class 001 — Chemicals: Chemicals, biological preparations, and biochemical preparations for use in industry and science; Chemicals for use in biotechnological manufacturing processes
- Class 005 — Pharmaceuticals: Chemical and biochemical preparations for pharmaceutical or medical purposes for the prevention and treatment of neurological, neurodegenerative, psychiatric, immune system related, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, urological, gynecological, reproductive, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, dermatological, lymphatic, inflammatory, infectious, hematological, renal, genetic, bacterial and viral diseases, sexual dysfunction, and pain; Biological reagents for medical purposes; Biologics in the nature of pharmaceutical preparations for the treatment of for the prevention and treatment of neurological, neurodegenerative, psychiatric, immune system related, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, urological, gynecological, reproductive, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, dermatological, lymphatic, inflammatory, infectious, hematological, renal, genetic, bacterial and viral diseases, sexual dysfunction, and pain; Biochemical reagents for medical purposes; Diagnostic preparations for medical purposes; Reagents for medical purposes; Vaccines; Pharmaceutical preparations for the prevention and treatment of neurological, neurodegenerative, psychiatric, immune system related, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, urological, gynecological, reproductive, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, dermatological, lymphatic, inflammatory, infectious, hematological, renal, genetic, bacterial and viral diseases, sexual dysfunction, and pain; Sedatives; Anaesthetics; Hypnotics; Anxiolytics; Muscle relaxants; Anticonvulsants; Analgesics; Antibiotic preparations; Antiparasitics; Antihypertensives; Antihypotensives; Pharmaceutical preparations, namely, immunostimulants; Pharmaceutical preparations for gene therapy for the treatment of neurological, neurodegenerative, psychiatric, immune system related, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, urological, gynecological, reproductive, oncological, hepatological, ophthalmic, respiratory, gastrointestinal, hormonal, dermatological, lymphatic, inflammatory, infectious, hematological, renal, genetic, bacterial and viral diseases, sexual dysfunction, and pain
- Class 035 — Advertising and business services: Wholesale store services, retail store services, mail order services, online wholesale store services, and online retail store services featuring chemical, biological, and biochemical preparations for industrial, scientific, medical, veterinary and pharmaceutical purposes, and also featuring diagnostic preparations for medical purposes, reagents for medical purposes, vaccines, pharmaceutical preparations, and pharmaceuticals
Owner
- Paion Pharma GmbH, DE
- Paion Pharma GmbH, DE
Prosecution history
- 24 Mar 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 24 Mar 2026 — PUBLISHED FOR OPPOSITION
- 18 Mar 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 27 Feb 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 27 Feb 2026 — EXAMINER'S AMENDMENT ENTERED
- 27 Feb 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 27 Feb 2026 — EXAMINERS AMENDMENT E-MAILED
- 27 Feb 2026 — EXAMINERS AMENDMENT -WRITTEN
- 21 Jan 2026 — TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
- 21 Jan 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 21 Jan 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 21 Jan 2026 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 21 Jan 2026 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 07 Nov 2025 — REFUSAL PROCESSED BY IB
- 17 Oct 2025 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB